Combined intrapleural and intravenous chemotherapy, and pulmonary irradiation, for treatment of patients with lung cancer presenting with malignant pleural effusion: A pilot study

Oncology

Volumn 64, Issue 1, 2003, Pages 18-24

  Su, Wu Chou ^a,c   Lai, Wu Wei ^a   Chen, Helen H W ^a   Hsiue, Tzuen Ren ^a   Chen, Cheng Wen ^a   Huang, Wen Tsung ^a   Chen, Tsai Yun ^a   Tsao, Chao Jung ^a   Wang, Nai San ^b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Combined modality; Intrapleural cisplatin; Non small cell lung cancer; Pleural effusion

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CISPLATIN; DOCETAXEL; GEMCITABINE;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALOPECIA; ANEMIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DYSPNEA; EDEMA; FEMALE; HUMAN; INFECTION; KIDNEY FUNCTION; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MALE; MUCOSA INFLAMMATION; NAUSEA; PLEURA EFFUSION; PRIORITY JOURNAL; RASH; RECURRENT DISEASE; SENSORY DYSFUNCTION; SURVIVAL RATE; THORAX PAIN; THROMBOCYTOPENIA; TREATMENT FAILURE; TREATMENT OUTCOME; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; DEOXYCYTIDINE; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRALESIONAL; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PILOT PROJECTS; PLEURAL EFFUSION, MALIGNANT; PLEURODESIS; RADIOTHERAPY, ADJUVANT; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 18744378558     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000066516     Document Type: Article

References (27)

1. Memon AN, Zawadzki ZA: Malignant effusions: Diagnostic evaluation and therapeutic strategy (review). Curr Probl Cancer 1981;5:1-30.
2. Anderson CB, Philpott GW, Ferguson TB: The treatment of malignant pleural effusions. Cancer 1974;33:916-922.
3. Sugiura S, Ando Y, Minami H, Ando M, Sakai S, Shimokata K: Prognostic value of pleural effusion in patients with non-small cell lung cancer. Clin Cancer Res 1997;3:47-50.
4. Naito T, Satoh H, Ishikawa H, Yamashita YT, Kamma H, Takahashi H, Ohtsuka M, Hasegawa S: Pleural effusion as a significant prognostic factor in non-small cell lung cancer. Anti-cancer Res 1997;17:4743-4746.
5. Hoffman PC, Mauer AM, Vokes EE: Lung cancer (review). Lancet 2000;355:479-485.
6. Chang SC, Lee LN, Kuo SH, Luh KT, Wu SC: Survival of patients with malignant pleural effusion (in Chinese). Taiwan Yi Xue Hui Za Zhi [J Form Med Assoc] 1987;86:672-678.
7. Yang SP, Luh KT, Kuo SH, Lin CC: Chronological observation of epidemiological characteristics of lung cancer in Taiwan with etiological consideration - A 30-year consecutive study. Jpn J Clin Oncol 1984;14:7-19.
8. Charloux A, Hedelin G, Dietemann A, Ifoundza T, Roeslin N, Pauli G, Quoix E: Prognostic value of histology in patients with non-small cell lung cancer. Lung Cancer 1997;17:123-134.
9. Light RW, Vargas FS: Pleural sclerosis for the treatment of pneumothorax and pleural effusion (review). Lung 1997;175:213-223.
10. Walker-Renard PB, Vaughan LM, Sahn SA: Chemical pleurodesis for malignant pleural effusions (review). Ann Intern Med 1994;120:56-64.
11. Rusch VW, Figlin R, Godwin D, Piantadosi S: Intrapleural cisplatin and cytarabine in the management of malignant pleural effusions: A Lung Cancer Study Group trial. J Clin Oncol 1991;9:313-319.
12. Tohda Y, Iwanaga T, Takada M, Yana T, Kawahara M, Negoro S, Okishio K, Kudoh S, Fukuoka M, Furuse K: Intrapleural administration of cisplatin and etoposide to treat malignant pleural effusions in patients with non-small cell lung cancer. Chemotherapy 1999;45:197-204.
13. Kubota K, Furuse K, Kawahara M, Kodama N, Yamamoto M, Ogawara M, Negoro S, Masuda N, Takada M, Matsui K: Role of radio-therapy in combined modality treatment of locally advanced non-small-cell lung cancer. J Clin Oncol 1994;12:1547-1552.
14. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
15. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-170.
16. Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, Krook J, Zhu J, Johnson DH: Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 2002;346:92-98.
17. Crino L, Scagliotti G, Marangolo M, Figoli F, Clerici M, De Marinis F, Salvati F, Cruciani G, Dogliotti L, Pucci F, Paccagnella A, Adamo V, Altavilla G, Incoronato P, Trippetti M, Mosconi AM, Santucci A, Sorbolini S, Oliva C, Tonato M: Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: A phase II study. J Clin Oncol 1997;15:297-303.
18. Ginsberg RJ, Vokes EE, Rosenzweig K: Non-small-cell lung cancer; in DeVita VT Jr, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology, ed 6. Philadelphia, Lippincott, 2001, p 926.
19. Lam KY, Fu KH, Wong MP, Wang EP: Significant changes in the distribution of histologic types of lung cancer in Hong Kong. Pathology 1993;25:103-105.
20. Lam CL, Lam WK, Tsang KWT, Ip MSM: Characteristics of young Chinese patients (less than 40 years of age) having carcinoma of lung compared to patients of older age group. Lung Cancer 2000;29(suppl):237.
21. Lam B, Lam CL, Lam WK, Ho JCM, Tsang KWT: Adenocarcinoma is not uncommon in non-smoking females. Lung Cancer 2000;29(suppl):238.
22. Gao YT, Blot WJ, Zheng W, Ershow AG, Hsu CW, Levin LI, Zhang R, Fraumeni JF Jr: Lung cancer among Chinese women. Int J Cancer 1987;40:604-609.
23. Shepherd FA, Dancey J, Ramlau R, Mattson K, Gralla R, O'Rourke M, Levitan N, Gressot L, Vincent M, Burkes R, Coughlin S, Kim Y, Berille J: Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy. J Clin Oncol 2000;18:2095-2103.
24. Putnam JB Jr, Light RW, Rodriguez RM, Ponn R, Olak J, Pollak JS, Lee RB, Payne DK, Graeber G, Kovitz KL: A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions. Cancer 1999;86:1992-1999.
25. Nio Y, Nagami H, Tamura K, Tsubono M, Nio M, Sato M, Kawabata K, Hayashi H, Shiraishi T, Imai S, Tsuchitani T, Mizuta J, Nakagawa M, Fukumoto M: Multi-institutional randomized clinical study on the comparative effects of intracavital chemotherapy alone versus immunotherapy alone versus immunochemotherapy for malignant effusion. Br J Cancer 1999;80:775-785.
26. Fujita A, Takabatake H, Tagaki S, Sekine K: Combination chemotherapy in patients with malignant pleural effusions from non-small cell lung cancer: Cisplatin, ifosfamide, and irinotecan with recombinant human granulocyte colony-stimulating factor support. Chest 2001;119:340-343.
27. Sculier JP, Lafitte JJ, Paesmans M, Thiriaux J, Alexopoulos CG, Baumohl J, Schmerber J, Koumakis G, Florin MC, Zacharias C, Berghmans T, Mommen P, Ninane V, Klastersky J: Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer. Br J Cancer 2000;83:1128-1135.